SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-293175
Filing Date
2020-11-13
Accepted
2020-11-13 17:04:52
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d74148d424b5.htm 424B5 297931
2 GRAPHIC g74148g05c73.jpg GRAPHIC 14930
3 GRAPHIC g74148g55l31.jpg GRAPHIC 44284
4 GRAPHIC g74148g78x47.jpg GRAPHIC 114394
  Complete submission text file 0001193125-20-293175.txt   538564
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-228206 | Film No.: 201312417
SIC: 2834 Pharmaceutical Preparations